Abstract:Blood is considered as the most valuable biofluid for protein biomarker screening as it contains a comprehensive human proteome, including cytokines and tissue leakage proteins that reflect ongoing disease states. Though widely used in large-scale protein quantification, mass spectrometry (MS)-based proteomic strategies still face great challenges in protein biomarker discovery in the blood, due to the particularly large dynamic range of proteins and the strong suppression effect by high-abundant proteins in the blood. As a promising alternative, nanomaterials enrichment-based protein corona strategy is highly efficient in increasing proteome coverage, but with the drawback of potentially disrupting the original protein concentration in the blood. Therefore, we proposed an ultrasensitive strategy that capable of enhancing mass spectrometry signals of the low abundant proteins/peptide to promote quantification of more than 2000 proteins at 288 SPD or 5000 plasma proteins at 36 SPD throughput from neat plasma without enrichment. Our strategy leverages the unique multiplexing properties of TMT labeling to sum the “total” MS1 signal of the same peptide from a boosting channel using nanomaterials enriched protein digests and the study channels using digests of neat plasma to trigger MS/MS fragmentation more efficiently and sensitively for low abundant protein identification, while the reporter ions provide quantitative information. In this way, in depth coverage of low abundant protein in neat plasma can be achieved without the risk of disrupting their original quantification. Accurate and reproducible quantification of plasma proteins with concentration down to low ng/L range was achieved, which is still rate in the field. Sensitive differentiation of plasma proteome characteristics among healthy individuals by this method indicated its potential in disease biomarker screening.

What problem does this paper attempt to address?

The main problem this paper attempts to address is improving the detection sensitivity and quantitative accuracy of plasma proteomics, particularly in the identification and quantification of low-abundance proteins. Specifically, the paper proposes an ultra-sensitive strategy that enhances the mass spectrometry signals of low-abundance proteins, enabling efficient and accurate identification and quantification of over 2000 proteins from unenriched plasma (at a throughput of 288 samples/day) or 5000 plasma proteins (at a throughput of 36 samples/day). ### Main Issues: 1. **Detection and Quantification of Low-Abundance Proteins**: - The abundance range of proteins in plasma is very large, and high-abundance proteins severely interfere with the detection and quantification of low-abundance proteins. - Commonly used immunoaffinity chromatography can partially remove high-abundance proteins, but its effectiveness is limited and it may co-remove low-abundance proteins, affecting quantitative accuracy. 2. **Limitations of Nanomaterial Enrichment Strategies**: - Nanomaterial enrichment techniques can significantly increase protein coverage but may disrupt the original protein concentrations in plasma, affecting quantitative accuracy. ### Solution: - **Nanomaterial-TMT-Boosting Strategy**: - Utilizing the protein corona structure formed by nanomaterials as an enhancement channel, the MS1 signals of low-abundance proteins are enhanced through isotopic labeling (TMT tags), thereby more efficiently triggering MS/MS fragmentation in unenriched plasma and improving the identification and quantification sensitivity of low-abundance proteins. - This strategy provides quantitative information through TMT reporter ions, ensuring accurate quantification of protein concentrations in the original plasma and avoiding the interference caused by enrichment or removal methods. ### Experimental Results: - **Significant Increase in Protein Identification**: - Without using enrichment methods, the number of proteins identified from untreated plasma increased fivefold through the nanomaterial-TMT-Boosting strategy. - **Sensitive Identification of Low-Abundance Proteins**: - This strategy can identify proteins of lower abundance than direct mass spectrometry analysis, making it particularly suitable for screening disease-derived biomarkers. - **Quantitative Accuracy and Reproducibility**: - By adding standard proteins (such as yeast alcohol dehydrogenase and yeast enolase) in different ratios, the strategy's high sensitivity and quantitative accuracy were validated at levels as low as 0.5 ppm. In summary, this paper proposes an innovative method that significantly enhances the detection and quantification capabilities of low-abundance proteins without disrupting the original protein concentrations in plasma, providing a new tool for the discovery of disease biomarkers.

An Ultra-Deep Quantitative Plasma Proteomics Strategy